Pfizer and BioNTech seek FDA authorization for 3-dose vaccine for children aged six months to five years, and WHO warns that fewer tests mean fewer cases detected
June 02, 2022 at 10:30 AM EDT
Pfizer Inc. and BioNTech SE have asked the U.S. Food and Drug Administration to authorize their three-dose vaccine for children aged six months to five years, in a move that could add roughly 19 million young children to the program.
